Kwangdong Pharmaceutical Launches Allergy Pre-Care 'Breathweet Allergy Blocker'

Kwangdong Pharmaceutical 'Bresweet Allergy Blocker'

[Asia Economy Reporter Chunhee Lee] Kwangdong Pharmaceutical announced on the 10th that it will launch 'BreatheSweet Allergy Blocker,' aimed at preventing contamination and providing protection against allergens causing allergic rhinitis.

BreatheSweet, approved as a spray-type medical device, sprays a barrier-forming substance inside the nose (nasal cavity) to block allergy-inducing substances. The fine powder, with hydroxypropyl methylcellulose (HPMC) as the main ingredient, absorbs moisture inside the nose to create a gel-type protective film. This protective film minimizes the entry of allergens into the body.

A Kwangdong Pharmaceutical official stated, “BreatheSweet is in a micro-particle powder form, so there is no concern about it dripping when sprayed inside the nose,” adding, "One spray can effectively protect against allergens for 4 to 6 hours, and it is widely sold in various countries including Europe.”

BreatheSweet is released in a 500 mg capacity, allowing approximately 200 sprays. When sprayed four times a day, it can be used for about 50 days. Since it does not contain medicinal ingredients, there is no risk of drug resistance or drowsiness, and clinical data is available for infants over 18 months and pregnant women.

Kwangdong Pharmaceutical has signed an exclusive sales contract with Menarini Korea for BreatheSweet, and both companies will jointly conduct sales and marketing.

This content was produced with the assistance of AI translation services.